China In Vitro Diagnostics Market Outlook to 2016

Introduction

GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the China In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics (IVD) market.
- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the China In Vitro Diagnostics (IVD) competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott LaboratoriesCompany Overview
Beckman Coulter, Inc.
Sysmex Corporation
Mindray Medical International Limited
OLYMPUS CORPORATION
Inverness Medical Innovations, Inc.
Becton, Dickinson and Company
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Hologic, Inc.
Ventana Medical Systems, Inc.
Ortho-Clinical Diagnostics Inc.
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB
Chengdu Perlong Medical Equipment Co., Ltd.
Shanghai Kehua Bio-engineering Co., Ltd.
China Medical Technologies, Inc.
Shanghai Genomics, Inc.
Beijing Chemclin Biotech Co., Ltd.
Beijing Pason Pharmaceuticals Inc.
Jingmei Biotech Co.,Ltd.
Beijing Bio-Ekon Biotechnology Co., Ltd.
China Sky One Medical, Inc.
Beijing Sekisui Trank Medical Technology Co., Ltd.
Shanghai Xunda Medical Instrument Co.,Ltd
Shanghai Fosun Medical Technology Development Co., Ltd.
Sichuan Nigale Biomedical Inc.
URIT Medical Electronic Group Co., Ltd
Rayto Life and Analytical Sciences Co., Ltd.
Bioson Corporation
Da An Gene Co., Ltd.
Shenzhen PG Biotech Co., Ltd.
Harbin First Bio-Engineering Co., Ltd
Beijing Shining Sun Technology Co., Ltd.
InTec Products, Inc
Zhongshan Bio-Tech Co., Ltd
Beijing BGI-GBI Biotech Co.,Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.,
GUANG ZHOU BGH BIOCHEMICAL CO.,LTD
[Cerrar las informaciones del articulo de mercado]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 In Vitro Diagnostics In China 17
3.1 In Vitro Diagnostics, Market Segmentation 17
3.2 In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 18
3.3 In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009 20
3.4 In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21
3.5 In Vitro Diagnostics, China, Company Share (2008-2009) 27
4 Clinical Chemistry In China 28
4.1 Clinical Chemistry, Market Segmentation 28
4.2 Clinical Chemistry Market, China, Revenue Mix ($m), 2009 29
4.3 Clinical Chemistry Market, China, Category Contribution (%), 2009 30
4.4 Clinical Chemistry Overall Revenue (2002-2016) 31
4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35
4.4.2 Urine Analysis Revenue (2002-2016) 39
4.5 Clinical Chemistry Distribution Share (2008-2009) 43
4.6 Clinical Chemistry, China, Company Share (2008-2009) 44
5 Genetic Testing In China 46
5.1 Genetic Testing, Market Segmentation 46
5.2 Genetic Testing Market, China, Revenue Mix ($m), 2009 47
5.3 Genetic Testing Market, China, Category Contribution (%), 2009 48
5.4 Genetic Testing Overall Revenue (2002-2016) 49
5.5 Genetic Testing Distribution Share (2008-2009) 53
5.6 Genetic Testing, China, Company Share (2008-2009) 54
6 Haematology In China 55
6.1 Haematology, Market Segmentation 55
6.2 Haematology Market, China, Revenue Mix ($m), 2009 56
6.3 Haematology Market, China, Category Contribution (%), 2009 57
6.4 Haematology Overall Revenue (2002-2016) 58
6.4.1 Haematology Reagents Revenue (2002-2016) 62
6.4.2 Immunohaematology Revenue (2002-2016) 66
6.4.3 Haemostasis Revenue (2002-2016) 70
6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74
6.4.5 Haematology Cell Counters Revenue (2002-2016) 78
6.5 Haematology Distribution Share (2008-2009) 82
6.6 Haematology, China, Company Share (2008-2009) 83
7 Histology And Cytology In China 85
7.1 Histology and Cytology, Market Segmentation 85
7.2 Histology and Cytology Market, China, Revenue Mix ($m), 2009 86
7.3 Histology And Cytology Market, China, Category Contribution (%), 2009 87
7.4 Histology And Cytology Overall Revenue (2002-2016) 88
7.4.1 Histology Revenue (2002-2016) 92
7.5 Histology And Cytology Distribution Share (2008-2009) 96
7.6 Histology And Cytology, China, Company Share (2008-2009) 97
8 Immuno Chemistry In China 98
8.1 Immuno Chemistry, Market Segmentation 98
8.2 Immuno Chemistry Market, China, Revenue Mix ($m), 2009 99
8.3 Immuno Chemistry Market, China, Category Contribution (%), 2009 100
8.4 Immuno Chemistry Overall Revenue (2002-2016) 101
8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 105
8.4.2 Drug Related Testing Revenue (2002-2016) 109
8.4.3 Endocrinology Tests Revenue (2002-2016) 112
8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 116
8.5 Immuno Chemistry Distribution Share (2008-2009) 120
8.6 Immuno Chemistry, China, Company Share (2008-2009) 121
9 Infectious Immunology In China 123
9.1 Infectious Immunology, Market Segmentation 123
9.2 Infectious Immunology Market, China, Revenue Mix ($m), 2009 124
9.3 Infectious Immunology Market, China, Category Contribution (%), 2009 125
9.4 Infectious Immunology Overall Revenue (2002-2016) 126
9.5 Infectious Immunology Distribution Share (2008-2009) 130
9.6 Infectious Immunology, China, Company Share (2008-2009) 131
10 Microbiology Culture In China 133
10.1 Microbiology Culture, Market Segmentation 133
10.2 Microbiology Culture Market, China, Revenue Mix ($m), 2009 134
10.3 Microbiology Culture Market, China, Category Contribution (%), 2009 135
10.4 Microbiology Culture Overall Revenue (2002-2016) 136
10.4.1 Microbiology Analyzers Revenue (2002-2016) 140
10.5 Microbiology Culture Distribution Share (2008-2009) 143
10.6 Microbiology Culture, China, Company Share (2008-2009) 144
11 Overview of Key Companies in China In Vitro Diagnostics Market 145
11.1 F. Hoffmann-La Roche Ltd. 145
11.1.1 Company Overview 145
11.1.2 Share in the China In Vitro Diagnostics Market 145
11.2 Siemens Healthcare 146
11.2.1 Company Overview 146
11.2.2 Share in the China In Vitro Diagnostics Market 146
11.3 Abbott LaboratoriesCompany Overview 147
11.3.1 Share in the China In Vitro Diagnostics Market 147
11.4 Beckman Coulter, Inc. 148
11.4.1 Company Overview 148
11.4.2 Share in the China In Vitro Diagnostics Market 148
11.5 Sysmex Corporation 149
11.5.1 Company Overview 149
11.5.2 Share in the China In Vitro Diagnostics Market 149
11.6 Mindray Medical International Limited 150
11.6.1 Company Overview 150
11.6.2 Share in the China In Vitro Diagnostics Market 150
11.7 OLYMPUS CORPORATION 151
11.7.1 Company Overview 151
11.8 Inverness Medical Innovations, Inc. 151
11.8.1 Company Overview 151
11.9 Becton, Dickinson and Company 152
11.9.1 Company Overview 152
11.10 bioMerieux S.A. 152
11.10.1 Company Overview 152
11.11 Bio-Rad Laboratories, Inc. 153
11.11.1 Company Overview 153
11.12 Hologic, Inc. 153
11.12.1 Company Overview 153
11.13 Ventana Medical Systems, Inc. 154
11.13.1 Company Overview 154
11.14 Ortho-Clinical Diagnostics Inc. 154
11.14.1 Company Overview 154
11.15 DiaSorin S.p.A 154
11.15.1 Company Overview 154
11.16 Qiagen N.V. 155
11.16.1 Company Overview 155
11.17 Gen-Probe Incorporated 155
11.17.1 Company Overview 155
11.18 Phadia AB 155
11.18.1 Company Overview 155
11.19 Chengdu Perlong Medical Equipment Co., Ltd. 156
11.19.1 Company Overview 156
11.20 Shanghai Kehua Bio-engineering Co., Ltd. 156
11.20.1 Company Overview 156
11.21 China Medical Technologies, Inc. 156
11.21.1 Company Overview 156
11.22 Shanghai Genomics, Inc. 157
11.22.1 Company Overview 157
11.23 Beijing Chemclin Biotech Co., Ltd. 157
11.23.1 Company Overview 157
11.24 Beijing Pason Pharmaceuticals Inc. 157
11.24.1 Company Overview 157
11.25 Jingmei Biotech Co.,Ltd. 158
11.25.1 Company Overview 158
11.26 Beijing Bio-Ekon Biotechnology Co., Ltd. 158
11.26.1 Company Overview 158
11.27 China Sky One Medical, Inc. 158
11.27.1 Company Overview 158
11.28 Beijing Sekisui Trank Medical Technology Co., Ltd. 159
11.28.1 Company Overview 159
11.29 Shanghai Xunda Medical Instrument Co.,Ltd 159
11.29.1 Company Overview 159
11.30 Shanghai Fosun Medical Technology Development Co., Ltd. 159
11.30.1 Company Overview 159
11.31 Sichuan Nigale Biomedical Inc. 160
11.31.1 Company Overview 160
11.32 URIT Medical Electronic Group Co., Ltd 160
11.32.1 Company Overview 160
11.33 Rayto Life and Analytical Sciences Co., Ltd. 160
11.33.1 Company Overview 160
11.34 Bioson Corporation 161
11.34.1 Company Overview 161
11.35 Da An Gene Co., Ltd. 161
11.35.1 Company Overview 161
11.36 Shenzhen PG Biotech Co., Ltd. 161
11.36.1 Company Overview 161
11.37 Harbin First Bio-Engineering Co., Ltd 161
11.37.1 Company Overview 161
11.38 Beijing Shining Sun Technology Co., Ltd. 162
11.38.1 Company Overview 162
11.39 InTec Products, Inc 162
11.39.1 Company Overview 162
11.40 Zhongshan Bio-Tech Co., Ltd 162
11.40.1 Company Overview 162
11.41 Beijing BGI-GBI Biotech Co.,Ltd. 162
11.41.1 Company Overview 162
11.42 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., 163
11.42.1 Company Overview 163
11.43 GUANG ZHOU BGH BIOCHEMICAL CO.,LTD 163
11.43.1 Company Overview 163
12 In Vitro Diagnostics Market Pipeline Products 164
12.1 Clinical Chemisty Market Pipeline Products 164
12.2 Immuno Chemistry Market Pipeline Products 166
12.3 Haematology Market Pipeline Products 167
12.4 Infectious Immunology Market Pipeline Products 168
12.5 Microbiology Culture Market Pipeline Products 170
12.6 Histology and Cytology Market Pipeline Products 171
12.7 Genetic Testing Market Pipeline Products 172
13 Financial Deals Landscape 174
13.1 Acquisition 174
13.1.1 CCS Capital to Acquire Beijing Biochem Hengye Science & Technology Development 174
13.1.2 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175
13.1.3 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176
13.2 Partnerships 177
13.2.1 QIAGEN Enters Into Distribution Agreement With Celera 177
13.2.2 Sequenom Enters Into Licensing Agreement With Optherion 178
13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179
13.2.4 Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech 180
13.2.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 181
13.2.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182
13.2.7 DxS Signs Cross-Licensing Agreement With Epigenomics 183
14 Recent Developments 184
14.1 Strategy and Business Planning 184
14.1.1 Sep 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai 184
14.2 Legal and Regulatory 184
14.2.1 Mar 08, 2010: Chinmax Medical Systems Files Complaint In China Against Inverness Medical Beijing Over Distribution Rights 184
14.3 Product News 185
14.3.1 Jun 09, 2010: China Medical Technologies Receives SFDA Approval For Its SPR-Based HPV-DNA Chip 185
14.3.2 Apr 14, 2010: HairDX Forms Alliance With GBIL To Distribute HairDX Genetic Hair Loss Tests In Hong Kong And Singapore 185
14.3.3 Dec 01, 2009: China Sky One Medical Distributes AMI Diagnostic Kit And Human Urinary Albumin Elisa Kit In Southeast Asia Through MDK 186
14.3.4 Nov 25, 2009: China Sky One Medical Achieves Milestone For Its Two New Biological Testing Kits 186
14.3.5 Oct 19, 2009: China Medical Technologies Receives SFDA Clearance For SPR System 187
15 Appendix 188
15.1 Definitions of Markets Covered in the Report 189
15.1.1 In Vitro Diagnostics 189
15.2 Research Methodology 197
15.3 Secondary Research 198
15.4 Primary Research 198
15.5 Models 199
15.6 Forecasts 199
15.7 Expert Panels 199
15.8 GlobalData Consulting 199
15.9 Currency Conversion 200
15.10 Contact Us 200
15.11 Disclaimer 200
[Cerrar la tabla de contenidos]

LIST OF TABLES

1.1 List of Tables
Table 1: In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 19
Table 2: In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21
Table 3: In Vitro Diagnostics, China, Cross-Category Analysis, 2002-2016 22
Table 4: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2002-2009 24
Table 5: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2009-2016 26
Table 6: In Vitro Diagnostics, China, Company Share by Revenue ($m), 2008-2009 27
Table 7: Clinical Chemistry Market, China, Category Contribution (%), 2009 30
Table 8: Clinical Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 32
Table 9: Clinical Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 34
Table 10: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36
Table 11: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38
Table 12: Urine Analysis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 13: Urine Analysis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42
Table 14: Clinical Chemistry, China, Distribution Share by Revenue ($m), 2008-2009 43
Table 15: Clinical Chemistry, China, Company Share by Revenue ($m), 2008-2009 45
Table 16: Genetic Testing Market, China, Category Contribution (%), 2009 48
Table 17: Genetic Testing, China, Revenue ($m) by Segment, Historic, 2002-2009 50
Table 18: Genetic Testing, China, Revenue ($m) by Segment, Forecast, 2009-2016 52
Table 19: Genetic Testing, China, Distribution Share by Revenue ($m), 2008-2009 53
Table 20: Genetic Testing, China, Company Share by Revenue ($m), 2008-2009 54
Table 21: Haematology Market, China, Category Contribution (%), 2009 57
Table 22: Haematology, China, Revenue ($m) by Segment, Historic, 2002-2009 59
Table 23: Haematology, China, Revenue ($m) by Segment, Forecast, 2009-2016 61
Table 24: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63
Table 25: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65
Table 26: Immunohaematology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67
Table 27: Immunohaematology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69
Table 28: Haemostasis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71
Table 29: Haemostasis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73
Table 30: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75
Table 31: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77
Table 32: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79
Table 33: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
Table 34: Haematology, China, Distribution Share by Revenue ($m), 2008-2009 82
Table 35: Haematology, China, Company Share by Revenue ($m), 2008-2009 84
Table 36: Histology And Cytology Market, China, Category Contribution (%), 2009 87
Table 37: Histology And Cytology, China, Revenue ($m) by Segment, Historic, 2002-2009 89
Table 38: Histology And Cytology, China, Revenue ($m) by Segment, Forecast, 2009-2016 91
Table 39: Histology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 93
Table 40: Histology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 95
Table 41: Histology And Cytology, China, Distribution Share by Revenue ($m), 2008-2009 96
Table 42: Histology And Cytology, China, Company Share by Revenue ($m), 2008-2009 97
Table 43: Immuno Chemistry Market, China, Category Contribution (%), 2009 100
Table 44: Immuno Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 102
Table 45: Immuno Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 104
Table 46: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106
Table 47: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108
Table 48: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109
Table 49: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 111
Table 50: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 113
Table 51: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 115
Table 52: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 117
Table 53: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 119
Table 54: Immuno Chemistry, China, Distribution Share by Revenue ($m), 2008-2009 120
Table 55: Immuno Chemistry, China, Company Share by Revenue ($m), 2008-2009 122
Table 56: Infectious Immunology Market, China, Category Contribution (%), 2009 125
Table 57: Infectious Immunology, China, Revenue ($m) by Segment, Historic, 2002-2009 127
Table 58: Infectious Immunology, China, Revenue ($m) by Segment, Forecast, 2009-2016 129
Table 59: Infectious Immunology, China, Distribution Share by Revenue ($m), 2008-2009 130
Table 60: Infectious Immunology, China, Company Share by Revenue ($m), 2008-2009 132
Table 61: Microbiology Culture Market, China, Category Contribution (%), 2009 135
Table 62: Microbiology Culture, China, Revenue ($m) by Segment, Historic, 2002-2009 137
Table 63: Microbiology Culture, China, Revenue ($m) by Segment, Forecast, 2009-2016 139
Table 64: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 141
Table 65: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 142
Table 66: Microbiology Culture, China, Distribution Share by Revenue ($m), 2008-2009 143
Table 67: Microbiology Culture, China, Company Share by Revenue ($m), 2008-2009 144
Table 68: Clinical Chemisty Market Pipeline Products 164
Table 69: Immuno Chemistry Market Pipeline Products 166
Table 70: Haematology Market Pipeline Products 167
Table 71: Infectious Immunology Market Pipeline Products 168
Table 72: Microbiology Culture Market Pipeline Products 170
Table 73: Histology and Cytology Market Pipeline Products 171
Table 74: Genetic Testing Market Pipeline Products 172
Table 75: CCS Capital To Acquire Beijing Biochem Hengye Science & Technology Development 174
Table 76: bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175
Table 77: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176
Table 78: QIAGEN Enters Into Distribution Agreement With Celera 177
Table 79: Sequenom Enters Into Licensing Agreement With Optherion 178
Table 80: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179
Table 81: Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech 180
Table 82: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 181
Table 83: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182
Table 84: DxS Signs Cross-Licensing Agreement With Epigenomics 183
Table 85: USD to Local Currency, China, Average Actual Rate 2002-2009 200
LIST OF FIGURES

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 17
Figure 2: In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 18
Figure 3: In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009 20
Figure 4: In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21
Figure 5: In Vitro Diagnostics, China, Cross-Category Analysis, 2002-2016 22
Figure 6: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2002-2009 23
Figure 7: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2009-2016 25
Figure 8: In Vitro Diagnostics, China, Company Share (%), 2009 27
Figure 9: Clinical Chemistry, Market Segmentation 28
Figure 10: Clinical Chemistry Market, China, Revenue Mix ($m), 2009 29
Figure 11: Clinical Chemistry Market, China, Category Contribution (%), 2009 30
Figure 12: Clinical Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 31
Figure 13: Clinical Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 33
Figure 14: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35
Figure 15: Clinical Chemisty Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37
Figure 16: Urine Analysis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39
Figure 17: Urine Analysis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 18: Clinical Chemistry, China, Company Share (%), 2009 44
Figure 19: Genetic Testing, Market Segmentation 46
Figure 20: Genetic Testing Market, China, Revenue Mix ($m), 2009 47
Figure 21: Genetic Testing Market, China, Category Contribution (%), 2009 48
Figure 22: Genetic Testing, China, Revenue ($m) by Segment, Historic, 2002-2009 49
Figure 23: Genetic Testing, China, Revenue ($m) by Segment, Forecast, 2009-2016 51
Figure 24: Genetic Testing, China, Company Share (%), 2009 54
Figure 25: Haematology, Market Segmentation 55
Figure 26: Haematology Market, China, Revenue Mix ($m), 2009 56
Figure 27: Haematology Market, China, Category Contribution (%), 2009 57
Figure 28: Haematology, China, Revenue ($m) by Segment, Historic, 2002-2009 58
Figure 29: Haematology, China, Revenue ($m) by Segment, Forecast, 2009-2016 60
Figure 30: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62
Figure 31: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64
Figure 32: Immunohaematology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66
Figure 33: Immunohaematology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68
Figure 34: Haemostasis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70
Figure 35: Haemostasis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72
Figure 36: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74
Figure 37: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76
Figure 38: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Figure 39: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80
Figure 40: Haematology, China, Company Share (%), 2009 83
Figure 41: Histology And Cytology, Market Segmentation 85
Figure 42: Histology And Cytology Market, China, Revenue Mix ($m), 2009 86
Figure 43: Histology And Cytology Market, China, Category Contribution (%), 2009 87
Figure 44: Histology And Cytology, China, Revenue ($m) by Segment, Historic, 2002-2009 88
Figure 45: Histology And Cytology, China, Revenue ($m) by Segment, Forecast, 2009-2016 90
Figure 46: Histology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92
Figure 47: Histology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94
Figure 48: Histology And Cytology, China, Company Share (%), 2009 97
Figure 49: Immuno Chemistry, Market Segmentation 98
Figure 50: Immuno Chemistry Market, China, Revenue Mix ($m), 2009 99
Figure 51: Immuno Chemistry Market, China, Category Contribution (%), 2009 100
Figure 52: Immuno Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 101
Figure 53: Immuno Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 103
Figure 54: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 105
Figure 55: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 107
Figure 56: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109
Figure 57: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 110
Figure 58: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 112
Figure 59: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 114
Figure 60: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 116
Figure 61: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 118
Figure 62: Immuno Chemistry, China, Company Share (%), 2009 121
Figure 63: Infectious Immunology, Market Segmentation 123
Figure 64: Infectious Immunology Market, China, Revenue Mix ($m), 2009 124
Figure 65: Infectious Immunology Market, China, Category Contribution (%), 2009 125
Figure 66: Infectious Immunology, China, Revenue ($m) by Segment, Historic, 2002-2009 126
Figure 67: Infectious Immunology, China, Revenue ($m) by Segment, Forecast, 2009-2016 128
Figure 68: Infectious Immunology, China, Company Share (%), 2009 131
Figure 69: Microbiology Culture, Market Segmentation 133
Figure 70: Microbiology Culture Market, China, Revenue Mix ($m), 2009 134
Figure 71: Microbiology Culture Market, China, Category Contribution (%), 2009 135
Figure 72: Microbiology Culture, China, Revenue ($m) by Segment, Historic, 2002-2009 136
Figure 73: Microbiology Culture, China, Revenue ($m) by Segment, Forecast, 2009-2016 138
Figure 74: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 140
Figure 75: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 142
Figure 76: Microbiology Culture, China, Company Share (%), 2009 144
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),China In Vitro Diagnostics Market, 2009 145
Figure 78: Siemens Healthcare, Company Share (%),China In Vitro Diagnostics Market, 2009 146
Figure 79: Abbott Laboratories, Company Share (%),China In Vitro Diagnostics Market, 2009 147
Figure 80: Beckman Coulter, Inc., Company Share (%),China In Vitro Diagnostics Market, 2009 148
Figure 81: Sysmex Corporation, Company Share (%),China In Vitro Diagnostics Market, 2009 149
Figure 82: Mindray Medical International Limited, Company Share (%),China In Vitro Diagnostics Market, 2009 150
Figure 83: GlobalData Methodology 197
[Ocultar lista de tablas / figuras]